Hematologic cancer—cancers of the blood, lymph nodes or bone marrow—can
happen to anyone. At Lankenau Medical Center, our medical team
recognizes this and is committed to providing each patient with
personalized care in the detection, treatment and follow-up care of all
Lankenau’s Hematologic Malignancies Program is dedicated to providing
experienced care for patients with all types of hematology cancers,
including acute lymphoblastic leukemia, acute myelogenous leukemia,
chronic lymphocytic leukemia, chronic myelogenous leukemia, acute
monocytic leukemia, Hodgkin’s lymphomas, non-Hodgkin’s lymphomas and
The Hematologic Malignancies Program is designed to help our team reach
an accurate and timely diagnosis. We offer the latest technology and
expertise in screening and detection of hematologic cancers.
The hematologic cancer team at Lankenau Medical Center is dedicated to
providing every patient with personalized care. Each plan is customized
so that patients receive the most-advanced, least-invasive treatments
with the fewest side effects. As often as possible, our team strives to
preserve healthy tissue while destroying the cancer at its point of
origin and any cancer that has spread.
All treatment options are available and discussed with you and your
family and decisions are made in a partnership approach. When
considering treatments, our team will find the one that works for you.
Age, overall health, location of the cancer, extent of the disease, and
your tolerance for specific treatments are all important factors in
determining an individualized and accurate treatment plan.
For more information, call 1.866.CALL.MLH.